Company Filing History:
Years Active: 2013-2025
Title: Innovations by Inventor Sun Young Jung
Introduction
Sun Young Jung is a notable inventor based in Daejeon, South Korea. She has made significant contributions to the field of materials science, particularly in the development of resin compositions and pharmaceutical methods. With a total of two patents to her name, her work has implications for both the food and drug industries.
Latest Patents
One of her latest patents is a polyethylene resin composition for injection-molding. This invention discloses a resin composition that is melt-mixed to exhibit excellent ductile and impact properties. It also demonstrates superior environmental stress crack resistance and low overall migration, making it suitable for use as a food and drug container or stopper. The composition consists of 80-90 wt % of a linear low-density polyethylene with a melt flow index of 15-30 dg/min and 10-20 wt % of an ethylene-alpha-olefin copolymer resin with a melt flow index of 10-20 wt %.
Another significant patent is a method for preparing entecavir and the intermediates used in this process. This invention presents a novel, high-yield method for synthesizing entecavir, which is crucial in the pharmaceutical industry.
Career Highlights
Throughout her career, Sun Young Jung has worked with prominent companies such as Lotte Chemical Corporation and Hanmi Science Co., Ltd. Her experience in these organizations has allowed her to refine her skills and contribute to innovative projects in the chemical and pharmaceutical sectors.
Collaborations
Sun Young Jung has collaborated with notable coworkers, including Kyung Hoon Kim and Dong Hoon Lee. These partnerships have facilitated the exchange of ideas and expertise, further enhancing her contributions to her field.
Conclusion
Sun Young Jung's innovative work in resin compositions and pharmaceutical methods showcases her expertise and commitment to advancing technology. Her patents reflect her ability to address real-world challenges in the food and drug industries.